Who owns PROCESSA PHARMACEUTICALS INC?
- Ticker: PCSA
- CUSIP Number: 74275c403
Tip: Access positions for across all investors
Analyze quarterly positions in Processa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Processa Pharmaceuticals stock
Who bought or sold PROCESSA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Connective Capital Management | 71k | $179k | 100% | Mar 2026 |
|
| Geode Capital Management | 25k | $63k | 63% | Mar 2026 |
|
| Vanguard Group | 24k | $68k | 100% | Dec 2025 |
|
| Vanguard Capital Management | 13k | $32k | 100% | Mar 2026 |
|
| Stonepine Capital Management | 12k | $36k | 100% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 11k | $27k | 100% | Mar 2026 |
|
| UBS Group | 2.5k | $6.4k | -80% | Mar 2026 |
|
| Tower Research Capital | 1.4k | $4.0k | 100% | Dec 2025 |
|
| Citigroup | 14.00 | $35.000000 | 100% | Mar 2026 |
|
| Jones Financial Companies, L.L | 7.00 | $19.999700 | 100% | Dec 2025 |
|
| Wells Fargo & Company | 6.00 | $15.000000 | 0% | Mar 2026 |
|
Who sold out of Processa Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Dec 2025 | 30k | $87k |
| Hrt Financial | Dec 2025 | 20k | $56k |